Lenox Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$66K Buy
2,139
+393
+23% +$13.4K 0.02% 227
2020
Q1
$54K Sell
1,746
-41
-2% -$1.4K 0.02% 240
2019
Q4
$66K Hold
1,787
0.02% 251
2019
Q3
$60K Sell
1,787
-34
-2% -$1.24K 0.02% 248
2019
Q2
$74K Buy
1,821
+832
+84% +$33K 0.02% 215
2019
Q1
$40K Hold
989
0.01% 260
2018
Q4
$41K Hold
989
0.01% 221
2018
Q3
$41K Sell
989
-547
-36% -$21.1K 0.01% 250
2018
Q2
$53K Hold
1,536
0.02% 213
2018
Q1
$51K Buy
1,536
+97
+7% +$3.33K 0.02% 208
2017
Q4
$49K Sell
1,439
-333
-19% -$11.4K 0.01% 210
2017
Q3
$60K Buy
1,772
+580
+49% +$18.6K 0.02% 203
2017
Q2
$38K Sell
1,192
-488
-29% -$15.4K 0.02% 228
2017
Q1
$55K Sell
1,680
-961
-36% -$30.3K 0.04% 88
2016
Q4
$81K Buy
2,641
+1,277
+94% +$39K 0.06% 75
2016
Q3
$44K Sell
1,364
-316
-19% -$10.6K 0.03% 107
2016
Q2
$56K Sell
1,680
-272
-14% -$8.68K 0.04% 97
2016
Q1
$55K Buy
1,952
+721
+59% +$20.6K 0.04% 103
2015
Q4
$38K Hold
1,231
0.03% 120
2015
Q3
$37K Sell
1,231
-23
-2% -$737 0.03% 81
2015
Q2
$40K Sell
1,254
-156
-11% -$5.08K 0.03% 80
2015
Q1
$47K Buy
1,410
+179
+15% +$5.69K 0.03% 83
2014
Q4
$36K Hold
1,231
0.02% 89
2014
Q3
$35K Buy
1,231
+45
+4% +$1.26K 0.02% 93
2014
Q2
$33K Buy
1,186
+405
+52% +$11.5K 0.02% 94
2014
Q1
$24K Hold
781
0.01% 109
2013
Q4
$23K Buy
+781
New +$22.7K 0.02% 118

Other funds holding PFE

Lenox Wealth Management's PFE Position: Q2 2020 in Review

Lenox Wealth Management increased its Pfizer (PFE) stake by 23% in Q2 2020, buying an estimated $13.4K and bringing the position to 2,139 shares worth $66K. The position accounts for 0.02% of the portfolio, ranked #227.

Lenox Wealth Management first reported a position in PFE in Q4 2013 and has held it in 27 quarters since. The position peaked at $81K in Q4 2016. 2,441 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

  • Lenox Wealth Management held 2,139 shares of Pfizer worth $66K as of Q2 2020.
  • Lenox Wealth Management bought 393 Pfizer shares in Q2 2020, an estimated $13.4K.
  • Pfizer made up 0.02% of Lenox Wealth Management's portfolio in Q2 2020, its #227 holding.
  • Lenox Wealth Management first reported a position in Pfizer in Q4 2013 and has held it in 27 quarters since.
  • Lenox Wealth Management's Pfizer position peaked at $81K in Q4 2016.
  • 2,441 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on Lenox Wealth Management's 13F filing for Q2 2020, filed 28 Jul 2020.